Navigation Links
Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
Date:6/30/2009

latelet therapy. As a result, the GRAVITAS study is the first multi-center, placebo-controlled study to determine whether tailored antiplatelet therapy based on the results of the company's VerifyNow System and P2Y12 Test reduces major cardiovascular adverse events post-PCI. The trial is being coordinated by Scripps Advanced Clinical Trials.

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-cleared product for prasugrel and FDA-cleared products for aspirin, Plavix, ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of sanofi-aventis. 

    CONTACT:
    Jules Abraham
    Lippert/Heilshorn & Associates
    212-838-3777
    jabraham@lhai.com

    Timothy I. Still
    President and CEO
    Accumetrics
    858-404-8260
    press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
2. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
3. Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
4. Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obamas Announcement on Healthcare Reform
5. ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
6. Spherix Announces Positive Phase 2 Study Results
7. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
8. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
9. CoAxia, Inc. Announces $21.5M Series D Financing
10. Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs
11. Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , BOSTON, Nov. 20 The Uni... upheld an earlier District Court ruling yesterday...ge Wholesale Price (AWP) pharmaceutical litigation... (Logo: http://www.newscom.com/cgi-bin/prnh/20080...ment that awarded consumers who purchased the phar...
(Date:11/20/2009)... , CARY, N.C., Nov. 20 /PRNewswire-FirstCall...), a specialty pharmaceutical company focused on a...nt products primarily for the respiratory and rela... Warning Letter from the Food and Drug Administrat... tablets (Phenylephrine HCl 10 mg, Pyrilamine Male...
(Date:11/20/2009)... , GLENWOOD, Ill., Nov. 20 /PRNewswire-FirstC...financial results for the fiscal fourth quarter an...r 1, 2009. ,, The company will host a conferenc... at 2:00 p.m. Eastern Time. Investors may access t...nited States and Canada), or 480-629-9835 (interna...
Breaking Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 1Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 2Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 3Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 4Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 5Virginia Hospital Center Seeks to Reduce Operating Costs and Improve Supply Chain with Broadlane 49001 6Clarient Launches New Gene Mutation Test to Help Select Therapy for Non Small Cell Lung Cancer 49000 1Clarient Launches New Gene Mutation Test to Help Select Therapy for Non Small Cell Lung Cancer 49000 2Clarient Launches New Gene Mutation Test to Help Select Therapy for Non Small Cell Lung Cancer 49000 3Clarient Launches New Gene Mutation Test to Help Select Therapy for Non Small Cell Lung Cancer 49000 4Greater Cincinnati Behavioral Health Services Standardizes on Autonomys Meaning Based Technologies 48996 1Greater Cincinnati Behavioral Health Services Standardizes on Autonomys Meaning Based Technologies 48996 2Greater Cincinnati Behavioral Health Services Standardizes on Autonomys Meaning Based Technologies 48996 3
...AMILTON, Bermuda, Dec. 16 Celtic Pharmaceutical ...at the databases have been locked and preliminary ...es of XERECEPT (R) (corticorelin acetate), as a t...n initial database lock on the open-label study of... The results of these studies are the subject of ...
...mber 18, 2008 at 9 a.m. Eastern Time , , VAL...asdaq: MNKD ) will host a live broadcast to revi...dies of AFRESA(TM), the company,s ultra rapid acti...e on Thursday, December 18, 2008. , , To pa...al (888) 677-5721 or (210) 839-8507. Those intere...
Other Medicine Technology:Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009 2MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes 2
(Date:11/21/2009)... WASHINGTON, Nov. 21 DN...t after the Senate voted to begin full debate of h... http://www.newscom.com/cgi-bin/prnh/20080519/DNCL...oric step on the road to enacting health insurance... senators will now have an opportunity to debate t...
(Date:11/21/2009)..., WASHINGTON, Nov. 21 A...inate onchocerciasis (river blindness) in the Amer...he disease in recent years, as evidenced by a 31% ...ss drug administration in six endemic countries. ...ting of the American Society of Tropical Medicine ...
(Date:11/21/2009)... NH based medical credentialing soft... industry to form a partnerhsip with Amerinet, Inc... partnership will help to transform quality care w... (Vocus) November 21, 2009 -- ISG Group, LLC,...d a new agreement with Amerinet Inc., a leading na...
(Date:11/21/2009)... Eric J. Hall, president and chief e...America (AFA) issued the following statement regar...on as part of the new annual wellness for Medicare... Affordable Care Act" that was introduced las...PRWEB) November 21, 2009 -- Eric J. Hall, presiden...
(Date:11/20/2009)...Pioneering Neurologist Closer to Understanding Bra...PRNewswire-USNewswire/ -- Dr. Jeremy Schmahmann, P...d neurologist at the Massachusetts General Hospita...is laboratory,s research on the new field of study...nk Foundation. ,, Dr. Schmahmann is an award-wi...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...n Light of Unresolved Audit Issues, VIRGINIA BEAC...UP DC was notified that it was one of four success...f Columbia,s Medicaid managed,care business. The c..., 2008., Yesterday, the Company notified the Dist...
...Customer Convenience and Increase Sales, SHENZHEN...l/ -- China,Nepstar Chain Drugstore Ltd. (NYSE: N...st drugstore chain in China based on the number of...nsCard POS equipment (TransCard POS readers) in al...
...er Seals is shining the,spotlight on its services ... array of services the national nonprofit provides...., Over the last 20 years, Easter Seals has seen ... with autism* --,that,s a new diagnosis every 20 m...
...he forefront in Massachusetts health,reform, repo...ies, BOSTON, April 2, 2008 A report released,tod... finds that, overall,primary care physicians in Ma...ortunities to improve health outcomes and,control ...
...8 The American College of Physicians (ACP) has jo...mployer organizations to endorse the Patient Chart...g and Tiering Programs. These organizations believ...n of such programs, coupled with full public discl...
...April 1, 2008 ,CompareNetworks, Inc., a global onl...lthcare industries, today announced that it has cl...., Based in South San Francisco, California, Comp...ks sites,which include biocompare.com, medcompare....
Other Medicine News:Health News:AMERIGROUP Successful Bidder in DC RFP 2Health News:China Nepstar Chain Drugstore to Accept TransCard at Shenzhen Outlets 2Health News:China Nepstar Chain Drugstore to Accept TransCard at Shenzhen Outlets 3Health News:China Nepstar Chain Drugstore to Accept TransCard at Shenzhen Outlets 4Health News:Easter Seals Celebrates World Autism Awareness Day With Campaign to Highlight Nationwide Services Available to Families Living With Autism Today 2Health News:Massachusetts Health Quality Partners Issues 2008 Report on Quality of Care 2Health News:Massachusetts Health Quality Partners Issues 2008 Report on Quality of Care 3Health News:Massachusetts Health Quality Partners Issues 2008 Report on Quality of Care 4Health News:Massachusetts Health Quality Partners Issues 2008 Report on Quality of Care 5Health News:Massachusetts Health Quality Partners Issues 2008 Report on Quality of Care 6Health News:Patient charter ensures that reports on physicians are meaningful, reliable, and fair 2Health News:CompareNetworks, Inc. Fuels Growth by Raising Round of Financing 2
...ep A Test is a color immunochromatographic assay u...ody labeled color particles coated at two separate...sensitivity than the conventional single label tec...st procedure, a throat swab is subjected to a chem...
... test is an easy to use, one step, lateral flow ra...s of determining the amount of follicle stimulatin...e test is performed two days after the onset of me... in design and use to a pregnancy test or an ovula...
... System delivers an unmatched combination of speed...olution for assessing and monitoring a patient's A...ere ., ,The CLIA-waived Cholestech GDX requ...sults in less than 5 minutes. The system is a prov...
... System, using patented, innovative technology, me...LT in only 5 minutes from a simple fingerstick. Wi...unction results. The scope of its measurement capa...roviders. The physician, nurse or technician can n...
Medicine Products: